How to allay your patients' concerns about that C.D.C. case of purported oral-oral transmission
PAUL A. VOLBERDING, M.D.
OPTIMAL MEDICAL MANAGEMENT
The clinical features, diagnosis, and treatment of TB in patients with HIV infection
ROBERT M. JASMER, M.D., and LAURENCE HUANG, M.D.
Predictors of TB infection: Geographical region and induration size of positive PPD test help identify those at risk... Isoniazid in HIV-positive patients at high risk for TB: Six months of prophylaxis produces no benefit... C.D.C. data can help clinicians identify patients at high risk for drug-resistant TB... Combivir®, first two-in-one antiretroviral agent, wins F.D.A. approval..."Prevention Works!," an update: Skills-building prevention programs for men who have sex with men prove effective -- and cost-effective as well... Broad-based prevention programs have little impact on high-risk behavior, but targeted interventions produce results... Transmission risk can be reduced among IDUs, but only when indirect
risks are also addressed...
Plus: Guidelines for the Administration of Protease Inhibitors and Rifampin in HIV-Positive Patients with Tuberculosis
PULL OUT AND SAVE
A list of low-fat and no-fat snacks that your patients can take along
with their indinavir dose, if they need to eat at a scheduled dosing time
Is this individual a candidate for aggressive suppression therapy?
HARVEY J. MAKADON, M.D.
This article was provided by San Francisco General Hospital. It is a part of the publication HIV Newsline.